Background/Aim: Increased mucin secretion is a characteristic feature of many chronic airway diseases, particularly during periods of exacerbation; however, the exact mechanism of mucin secretion remains unclear. Ezrin, which is a specific marker of apical membranes, is predominantly concentrated in exocyst-rich cell surface structures, crosslinking the actin cytoskeleton with the plasma membrane. In the present study, we examined whether Ezrin is involved in mucin 5AC (MUC5AC) secretion after neutrophil elastase (NE) attack, and we investigated the role of the exocyst complex docking protein Sec3 in this process. Methods: NE was used as a stimulator in a 16HBE14o-cell culture model. The expression and location of Ezrin and Sec3 were investigated, and the interaction between Ezrin and Sec3 in 16HBE14o-cells was assayed after treatment with NE, Ezrin siRNA, Sec3 siRNA, neomycin or PIP2-Ab. Results: We found that Ezrin was highly expressed in the bronchi of humans with chronic airway diseases. NE induced robust MUC5AC protein secretion. The Ezrin siRNA, Sec3 siRNA, and neomycin treatments led to impaired MUC5AC secretion in cells. Both Ezrin and Sec3 were recruited primarily to the cytoplasmic membrane after NE stimulation, and the neomycin and PIP2-Ab treatments abrogated this effect. Immunoprecipitation analysis revealed that Ezrin and Sec3 combined to form complexes; however, these complexes could not be detected in Ezrin △1-333 mutant-transfected cells, even when PIP2 was added. Conclusions: These results demonstrate that Ezrin/Sec3 complexes are essential for MUC5AC secretion in NE-stimulated airway epithelial cells and that PIP2 is of critical importance in the formation of these complexes.
Tissues
Normal human lung tissues were obtained from surgical specimens resected at the Department of Thoracic Surgery of the Second Affiliated Hospital (Chongqing Medical University) between 2011 and 2012. The experiments were approved by the institutional ethics committee, and informed consent was obtained before sampling. The samples were collected from 10 patients (8 men and 2 women) with a mean age of 56 years (age range: 45-69 years). At the time of surgery, 6 patients were suffering from mild to moderate COPD or asthma, and 4 patients had no underlying chronic inflammatory diseases of the airway. None of the patients was being chronically treated with theophylline, β-adrenoceptor agonists, corticosteroids, or anticholinergic drugs. Hematoxylin and eosin (HE) staining was used to confirm whether the tissues were non-cancerous.
Immunohistochemistry
Tissue slides were incubated with a mouse anti-Ezrin monoclonal antibody (1:500 dilution) at room temperature for 1 h and then incubated with a rabbit anti-mouse antibody (1:200 dilution) for 30 min. Then, samples were exposed to a streptavidin-peroxidase complex (1:100 dilution) for another 45 min. 3,3'-Diaminobenzidine (DAB) was used as a chromogen. Epithelial cells that stained positively for Ezrin were counted; the results are expressed as a percentage of the total number of epithelial cells.
Construction of recombinant Flag-Ezrin and a Flag-Ezrin 1-333 deletion mutant
Total RNA was extracted from 16HBE14o-cells. The following primers were used to amplify the Ezrin sequence by PCR: forward primer, 5′-GCG AAG CTT GAT TAC AAG GAC GAC GAT GAC AAG ACC GAA ACC AAT CAA TGT C-3′ (the BamH I restriction site is underlined, and the Flag sequence is in italics), and reverse primer, 5′-GCG GGA TCC TTA CAG GGC CTC GAA CTC-3′ (the HindIII restriction site is underlined). PCR was performed using Platinum Taq DNA Polymerase High Fidelity (Invitrogen) to obtain full-length Ezrin cDNA. The pcDNA3.1 vector was cut at unique BamH I and Hind III restriction sites, and the purified Ezrin cDNA was subcloned into the linear pcDNA3.1 vector using T4 DNA ligase to obtain pcDNA.3-Flag-Ezrin. The region in Ezrin that is responsible for PIP2 binding is in the 1-333 NH2-terminal domain; thus, we constructed an Ezrin 1-333 deletion mutant for further study. The pGEX-2T-Ezrin △1-333 plasmid used to express the Ezrin 1-333 truncated mutant was constructed as described previously [15] [16] [17] . The Ezrin △1-333 fragment was purified and subcloned into the pcDNA3.1-Flag vector to obtain pcDNA.3-Flag-Ezrin △1-333 .
Cell culture 16HBE14o-cells were cultured in RPMI-1640 supplemented with 10% (v/v) fetal bovine serum (FBS). Then, the cells were plated at a density of 1×10 6 -2×10 6 cells/ml and incubated at 37°C until the cells were 60%-80% confluent. The cells were serum-starved before NE exposure. For inhibition studies, the cells were pre-treated with inhibitors for 1 h before infection.
siRNA transfection 16HBE14o-airway epithelial cells were plated at a density of 1×10 6 -2×10 6 cells/ml and incubated at 37°C until the cells were 60%-80% confluent. Then, 4 μl of X-tremeGENE9 DNA transfection reagent was diluted in serum-free DMEM/Ham's F12 medium. After vortexing briefly, Ezrin siRNA or Sec3 siRNA (both 1 μg) was added to the reagent. The mixture was incubated at room temperature for 20 min. Then, the mixture was added dropwise to cells and incubated for 18 h. Next, the cells were washed 3 times with PBS and incubated in DMEM/Ham's F12 medium containing 10% FBS for the following assays.
Real-time PCR and reverse transcription PCR
Total RNA was extracted from each group of 16HBE14o-cells using a Bioteke high-purity total RNA extraction kit and verified by 1.5% agarose gel electrophoresis. RNA was primed with oligo(dT) and reverse transcribed using a PrimeScript RT reagent kit. The conditions for the reverse transcription reaction were as follows: denaturing at 94°C for 10 min; followed by 30 cycles of 94°C for 30 s, 60°C for 45 s, and 70°C for 45 s; and a final extension at 72°C for 5 min. The PCR products were resolved by 2% agarose gel electrophoresis and subsequently visualized by ethidium bromide staining. Real-time PCR was performed using a SYBRR Premix EX Taq TM II real time PCR kit. The human Ezrin primer sequences for real-time PCR are listed in TableLi 
ELISA
ELISA for the MUC5AC protein was performed as described previously [18] .
Immunoprecipitation
Protein samples were lysed using RIPA buffer and then collected, and IgG was used to prevent nonspecific binding. The anti-Ezrin antibody (1 µg) was added to each sample and then rotated at 4°C overnight. Then, 20 µl of protein A+G agarose was added, and the samples were rotated at 4°C for 3 h. Next, the samples were centrifuged at 2500 pm for 5 min at 4°C. The pellet was washed with RIPA buffer 5 times, centrifuged, resuspended in 20 µl of buffer solution, and heated at 100°C for 5 min. The immunoprecipitates were fractionated by SDS-PAGE and then transferred onto polyvinylidene difluoride (PVDF) membranes for immunoblotting for Flag-Ezrin and Sec3 proteins.
Immunoblotting
The proteins in cell lysates were extracted and resolved on 6% SDS gels. The gels were equilibrated in transfer buffer containing 25 mM Tris-HCl, 192 mM glycine, and 20% methanol (pH 8.3). Then, the proteins were transferred to PVDF membranes by electrophoresis. The membranes were incubated in 5% milk dissolved in PBS and 0.05% Tween-20 for 1 h at room temperature and subsequently incubated with pEzrin, Ezrin, and Sec3 antibodies overnight at 4°C. After incubation with secondary IgG antibody, the immunoreactivity was visualized using an enhanced chemiluminescence detection reagent.
Immunofluorescence
Cells were fixed with 4% paraformaldehyde and then permeabilized with 0.1% Triton X-100 in PBS for 30 min. The cells were rinsed, blocked with 1% BSA plus 1% normal goat serum and then incubated with a mouse anti-Ezrin monoclonal antibody (1:200) overnight at 4°C. After three 10-min washes in 0.1% Triton X-100/PBS, the cells were incubated with a FITC-conjugated fluorescent secondary antibody (1:200) for 2 h at room temperature, followed by staining of the cell nuclei with diamidino-phenyl-indole (DAPI). The samples were examined using a Leica TCS-SP2 inverted confocal microscope fitted with the appropriate fluorescence filters.
Statistical analysis
The data are presented as the mean±SEM. The data analysis was performed using SPSS 17.0 software (SPSS Inc., USA). All in vitro experiments that used cell lines were performed with materials collected from at least six separate cell cultures in duplicate or triplicate. More than two groups were compared using Student's t-test or one-way analysis of variance (ANOVA), followed by Bonferroni analysis with a significance value defined as P<0.05.
Results

Ezrin expression in human bronchial epithelial cells
Ezrin was highly expressed in the mucosal epithelium of bronchi affected by chronic inflammation. This protein was primarily at the apical membrane near the cavosurface (Fig.  1A-D) . The brown areas (positive areas stained by Ezrin antibody) were selected as areas of interest (AOIs), and the integrated optical density/area (IOD/area) was calculated using Image-Pro Plus 6.0 software. The data were analyzed using one-way analysis of variance (ANOVA), followed by Bonferroni analysis. The results revealed that the intensity (IOD/area) of the positive area for the epithelium samples from patients with chronic inflammation was higher than that for normal epithelium samples (Fig. 1E ). Thus, airway epithelial cells under chronic inflammation expressed more Ezrin than normal epithelial cells.
NE induced Ezrin expression and phosphorylation in 16HBE14o-cells
Cells were treated with 0.5 μM NE. Ezrin mRNA expression was upregulated by NE in a time-dependent manner, with the level of Ezrin mRNA expression increasing at 20 min and 30 min ( Fig. 2A and B) . We also assayed total Ezrin and phosphorylated Ezrin (pEzrin) protein levels using western blot. β-Actin was used as the loading control. The results showed that NE induced Ezrin phosphorylation in a time-dependent manner; the pEzrin protein level began to increase at 5 min after NE incubation, and the pEzrin protein was greatly increased at 20 min compared with that of the cells at time 0. Additionally, the total Ezrin protein level increased at the 30 min period ( Fig. 2C and D) . These results revealed that NE, which is a potent agent that leads to mucin secretion, also has the ability to increase the mRNA and protein expression levels of Ezrin and to increase the activated state of the Ezrin protein.
NE stimulated both Ezrin and Sec3 to localize to the plasma membrane
Immunofluorescence analysis showed that Ezrin was predominantly diffuse throughout the cytoplasm in normal cells without any treatment (Fig. 3A) . NE stimulation led to the accumulation of Ezrin at the apical membrane (Fig. 3B) . Then, we pretreated cells with 10 mM neomycin for 30 min before NE stimulation. Neomycin is a positively charged aminoglycoside Ezrin expression in the bronchial epithelia of subjects with COPD and of control subjects. Tissues were immunostained with a mouse anti-Ezrin monoclonal antibody (1:500 dilution) at room temperature for 1 h and then incubated with a rabbit anti-mouse antibody (1:200 dilution) for 30 min. Then, samples were exposed to a streptavidin-peroxidase complex (1:100 dilution) for another 45 min. 3,3'-Diaminobenzidine (DAB) was used as a chromogen. Epithelial cells that stained positively for Ezrin were counted. The data were analyzed using one-way analysis of variance (ANOVA), followed by Bonferroni analysis. The results are expressed as a percentage of the total number of epithelial cells. Significance was set at P<0.05 (A) Normal controls, (B) COPD group, (C) negative control group (rabbit IgG), (D) blocking peptide group (rabbit Ezrin antibody-specific peptide to block the first antibody), and (E) Ezrin protein expression in the airway epithelium (IOD/ area). *: Compared with normal control group, P<0.01. Li 
antibiotic known to sequester PIP2 with high affinity. This dose of neomycin was chosen based on a previous study performed by Missiaen et al. [19] . In neomycin-incubated cells, Ezrin was predominantly dispersed in the cytoplasm, which was a significantly different pattern compared with that in the NE-treated cells not exposed to neomycin ( Fig. 3C and D) . We also found that Sec3 expression increased in NE-stimulated cells and that this protein showed the same tendency to localize to the cell surface. Neomycin treatment decreased the accumulation of Sec3 at the cell surface, which is a significantly different result compared with that for NE-treated cells (P<0.05) ( Fig. 3C and D) . These results demonstrated that NE could stimulate both Ezrin and Sec3 to localize to the cell surface.
Ezrin and Sec3 levels in the plasma membrane were reduced by neomycin and by PIP2-Ab Previous analyses of various membrane markers have shown that exocyst components are primarily found in the plasma membrane 2 (P2) fraction [20] . Therefore, the association of the exocyst with the plasma membrane can be assessed by determining the level of this complex in the P2 fraction. The levels of Sec3 and Ezrin in the P2 fraction were determined by immunoblotting. Cell lysates were centrifuged successively at 500 g and 13000 g for 10 min to generate the S1 (cytosol fraction 1), P1 (plasma membrane fraction 1), S2 (cytosol fraction 2) and P2 fractions as previously described [20] . The results revealed that the levels of both Ezrin and Sec3 in the P2 fraction of NE-treated cells were higher compared with those in the P2 fraction of negative control cells (P<0.01). When the PIP2-masking reagent neomycin was added, the levels of both Ezrin and Sec3 in the P2 fraction decreased compared with those of the NE-treated group; however, Ezrin and Sec3 protein levels did not show significant changes in the S1 and S2 fractions when the PIP2-masking reagent neomycin was added. Then, we treated cells with 20 μg/ml of PIP2 antibody (PIP2-Ab), which could reduce PIP2 
MUC5AC protein secretion inhibited by Ezrin siRNA, Sec3 siRNA, neomycin and PIP2-Ab
Cells were transfected with Ezrin siRNA and then stimulated with NE for 30 min. MUC5AC protein secretion into the supernatant of the cultured cells was decreased compared with that in non-transfected cells; however, no obvious change in the level of MUC5AC in the cytoplasm was observed (Fig. 5A) . The MUC5AC protein level in the supernatant was also reduced in Sec3 siRNA-transfected cells compared with that in non-transfected cells (Fig.  5A) . To investigate the role of PIP2 in this process, Ezrin siRNA-or Sec3 siRNA-transfected cells were preincubated with 20 μM PIP2 before NE incubation. The PIP2 dose was chosen according to the study of Kim et al. [21] . The results showed that PIP2 could increase the MUC5AC protein level in the cytoplasm but not in the supernatant of Ezrin siRNA-transfected cells after NE stimulation. An identical effect was detected in Sec3 siRNA-transfected cells preincubated with PIP2 before NE stimulation (Fig. 5A) . Thus, the effect of NE on MUC5AC secretion into the supernatant was attenuated in Ezrin-and Sec3-inhibited cells, even when exogenous PIP2 was added. These results indicated that Ezrin and Sec3 were involved in NE-induced MUC5AC protein secretion into the supernatant but not in MUC5AC protein production in the cytoplasm. In the present study, we found that PIP2 could increase MUC5AC protein levels in the cytoplasm under NE stimulation in the Ezrin siRNA-and Sec3 siRNA-transfected cells. To further study the role of PIP2, these cells were preincubated with 10 mM neomycin or 20 μg/ml of PIP2-Ab for 30 min before NE stimulation, and the MUC5AC protein levels in the supernatant and cytoplasm were assayed. The results showed that both neomycin and PIP2-Ab decreased the MUC5AC protein level in both the cell culture supernatant and cytoplasm (Fig. 5B) .
The above results revealed that exogenous PIP2 could increase the MUC5AC protein level in the cytoplasm but not in the supernatant of Ezrin siRNA-or Sec3 siRNA-transfected 
NE stimulates Ezrin binding to Sec3, and PIP2 is required for Ezrin-Sec3 binding
We found that NE stimulated both Ezrin and Sec3. We used immunoprecipitation assays to study their interaction further. Confluent 16HBE14o-cells were starved and stimulated with 0.5 μM NE for 30 min. Ezrin was immunoprecipitated with an anti-Ezrin antibody. The immunoprecipitates were analyzed by immunoblotting with antibodies to Ezrin and Sec3. The immunoprecipitation experiments showed that Ezrin bound to Sec3 (Fig. 6A and B) . Then, we transfected cells with Flag-Ezrin or Flag-Ezrin △1-333 ; some cells were also treated with 20 μM PIP2 for further evaluation. These cells were immunoprecipitated using a Flag antibody and then immunoblotted with a Sec3 antibody. We detected Sec3 in the samples immunoprecipitated by Flag, indicating that Ezrin and Sec3 interact under these conditions. For cells transfected with Flag-Ezrin and then stimulated with NE, the immunoprecipitation experiments showed that both Flag and Sec3 were expressed but no Sec3 protein was detected in the Flag-Ezrin △1-333 -transfected cells, even when PIP2 was added (Fig. 6C) . These results indicated that NE stimulates Ezrin binding to Sec3, that PIP2 is required for EzrinSec3 binding, and that the PIP2 binding site 1-333 in Ezrin is indispensable for PIP2 function. 
Discussion
Our results indicated that Ezrin was highly expressed in the bronchi of humans with chronic airway diseases. NE induced robust MUC5AC protein secretion into the supernatant and cell lysates in a 16HBE14o-cell culture model. MUC5AC secretion was impaired in culture supernatants when cells were transfected with Ezrin siRNA, and this effect was detected in Sec3 siRNA-transfected cells and in neomycin-or PIP2-Ab-treated cells. Both Ezrin and Sec3 were involved in MUC5AC secretion; this process primarily recruited Ezrin and Sec3 to the cytoplasmic membrane after NE stimulation, where these proteins combined to form complexes. PIP2 is of critical importance in the formation of these complexes and in MUC5AC secretion.
To our knowledge, this study is the first report of Ezrin activation in mucus exocytosis in airway epithelial cells. Excessive mucin secretion is a prominent feature in chronic airway diseases and can lead to airway obstruction and bacteria colonization [24, 25] . Mucus exocytosis is a complicated process that involves numerous factors, and this process has not been fully elucidated. We do not know precisely how the polarity of the mucus secretory granules develops or how the cell interacts with exocytosis-related proteins. In addition, mucin stored in the cytoplasm cannot increase suddenly. Studies have shown that more mucin is stored in the epithelium per unit surface area of basal lamina in the bronchi of smokers with airflow obstruction, indicative of the dysregulation of mucin secretion [26] . Mucin tends to exhibit a burst secretion pattern under pathological conditions or upon exposure to certain stimuli; this pattern differs from the basal pattern of secretion under physiological states.
Ezrin is primarily distributed in secretory organs and is highly expressed in the epidermis and mesothelium. In the present study, we demonstrated that Ezrin is highly expressed in bronchi from patients with chronic inflammation. Then, we used NE, which is a well-known potent inducer of mucin secretion, to generate the hypersecretion state. NE induced robust MUC5AC protein secretion into the supernatant and cell lysates, which is consistent with the results of previous studies [23, 27] . Ezrin mRNA expression was upregulated by NE stimulation; western blot assays showed that Ezrin activation also increased significantly and that Ezrin was translocated from the cytoplasm to the cell membrane after NE stimulation.
The ERM family belongs to the talin and band 4.1R (erythrocyte membrane-cytoskeleton linker protein band 4.1 R or EPB41) superfamily. Ezrin is an important member of the ERM family. This protein specifically binds to actin and serves as a crosslinker between the plasma membrane and the cytoskeleton [28, 29] . The Ezrin (NM-003379) gene is on chromosome 6q25.2-q26 and encodes 587 amino acids [30] . Amino acid residues 1-296 in the N-terminus form a 4.1 FERM (Ezrin/Radixin/Moesin) domain, and residues 1-333 contain a phosphatidylinositol 4,5-bisphosphate (PIP2) membrane binding site, which leads to conformational changes that stabilize the activation state of the C-terminus and which result in the localization of Ezrin at the plasma membrane [31, 32] . Residues 297-468 form the consecutive a-helix domain, which is called the central domain. Residues 460-474 are a string of proline residues, which could form a hinge region and thus could affect the conformational changes of Ezrin. The C-terminal ERM association domain (C-ERMAD) of Ezrin is formed by amino acid residues 478-586 and is also called the autoinhibitory C-terminal tail, which has the ability to bind to the plasma membrane. Amino acid residues 551-586 form the F-actin binding domain [33, 34] .
PIP2 can bind to Ezrin primarily through residues 253, 254, 262 and 263 in the NH2-terminus [35] . PIP2 binds to Ezrin, and the phosphorylation of Thr567 is essential for Ezrin to translocate to the apical membrane [36, 37] . We transfected cells with Ezrin siRNA to determine whether Ezrin and PIP2 are involved in NE-induced MUC5AC secretion. Ezrin siRNA transfection reduced the MUC5AC protein level in the culture supernatant but not the intracellular protein level, indicating that Ezrin was involved in NE-induced MUC5AC
protein secretion but not in MUC5AC protein production in the cytoplasm. Then, when exogenous PIP2 was added to Ezrin siRNA-transfected cells before NE stimulation, we found that the MUC5AC protein level in the supernatant remained at a relatively lower level but that the MUC5AC protein level in the cytoplasm increased. Thus, PIP2 participated in Ezrinmediated MUC5AC protein secretion into the supernatant and might be involved in MUC5AC production in the cytoplasm, which was independent of Ezrin. This finding may be because PIP2 is an important signal mediator in a series of mucin hypersecretion events initiated by many stimuli, such as proteases [22] and cold [23] . In addition, we found that neomycin, which is a PIP2-masking reagent, and PIP2-Ab led to impaired MUC5AC secretion in cells.
These results indicate that Ezrin is involved in MUC5AC secretion in 16HBE14o-cells and that PIP2 binding could be necessary for this process. The exocyst complex is essential for many exocystic events because this complex tethers vesicles to the plasma membrane for fusion [38] , as we described for mucin secretion. The exocyst is a conserved multi-subunit complex involved in the docking of post-Golgi transport vesicles to sites of membrane remodeling during cellular processes such as polarization, migration, and division [39, 40] . The exocyst complex is composed of Sec3, Sec5, Sec6, Sec8, Sec10, Sec15, Exo70, and Exo84. Sec3 and Exo70 interact with Rho family small GTPases, which are key regulators of polarized cell growth in yeast [41, 42] . Sec3 is regarded as a spatial landmark for the development of polarity in budding yeast cells and in epithelial cells. This protein has been implicated in coordinating the membrane targeting of the remaining members of the exocyst complex that travel on secretory granules [43] .
Sec3 is a docking protein of the exocyst complex that is required for secretion. The PHlike domain, which is formed by amino acids 1-140 in the NH2-terminus, has the ability to bind PIP2, phospholipids, GTPases (Rho1/Cdc42), and the β/γ subunit of G proteins [44] . Therefore, we also studied the Sec3 protein in airway epithelial cells to evaluate whether Ezrin is associated with exocyst-related proteins. Immunofluorescence and immunoblotting assays showed that Sec3 was recruited primarily to the plasma membrane after NE stimulation, which is consistent with the localization of Ezrin. This result is also consistent with those of another study [45] . The PIP2-msking reagent neomycin abrogated this effect. Furthermore, we used an Ezrin 1-333 deletion (Ezrin △1-333 ) mutant in this study to confirm the roles of PIP2 in regulating the function of Ezrin. Immunoprecipitation experiments revealed that Ezrin and Sec3 combined to form complexes; however, these complexes could not be detected in cells transfected with the Ezrin △1-333 mutant that lacks the PIP2 binding domain, even when exogenous PIP2 was added. These results demonstrate that Ezrin/Sec3 formed a complex and functioned together, contributing to MUC5AC secretion. These proteins did not interact directly; PIP2 acted as a linker and was required for complex formation and for MUC5AC secretion.
In summary, we presented evidence that the docking protein Sec3 is targeted to plasma membrane domains enriched in Ezrin after NE stimulation and that PIP2 is required for Sec3 binding to Ezrin. These events were followed by a higher level of MUC5AC secretion into the supernatant than occurs in normal static cells, indicating the involvement of these two proteins in the mucus secretion process. The specific functions and co-localization of Ezrin and Sec3 provide new potential therapeutic targets for the intervention of mucus hypersecretion in airway diseases.
